AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.8 MB)
Collect
AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Dahuang Fuzi decoction reduces inflammation levels and alleviates intestinal mucosal barrier damage in septic rats

Fusheng Liua,1Chunyue Yub,1Jin LiubNadia JohnsoncYin ZhangdZeqi SueChenchen SunaXia Dingf( )
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China
International School, Beijing University of Chinese Medicine, Beijing, 100700, China
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China
Beijing Academy of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China

Peer review under responsibility of Beijing University of Chinese Medicine.

Show Author Information

Abstract

Objective

To investigate the protective effect of Dahuang Fuzi Decoction (DHFZD), a traditional Chinese prescription, at alleviating sepsis-induced inflammation and gut barrier damage in rats.

Methods

Forty clean-grade male Sprague-Dawley rats were divided randomly into three groups: normal control group (NCG, n = 10), model control group (MCG, n = 15) and DHFZD-treated group (DHFZDG, n = 15). NCG rats were sham operated on and used as the controls, whereas MCG and DHFZDG rats were used to replicate the rat sepsis model using cecal ligation and puncture (CLP). The DHFZDG rats received DHFZD by gavage (4.5 mg/g of body weight) 2 h prior to CLP and after its successful induction, while the NCG and MCG rats received equivalent amounts of sterilized water by gavage. All rat groups were starved and had free access to water. At 24 h post-experimental set up, the mortality of rats in each group was recorded, and peritoneal inflammation assessment and pathological changes related to the intestinal mucosal injury index (IMII) in the surviving rats were evaluated. D-lactic acid, tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10 peripheral blood concentrations, along with secretory immunoglobulin A (sIgA) in the intestinal mucosa were evaluated by enzyme-linked immunosorbent assays. Gut microbes were detected using 16S rRNA gene sequencing.

Results

DHFZD reduced sepsis-related mortality in the rats. Moreover, it alleviated peritoneal inflammation and pathological changes according to the IMII. DHFZD reduced serum procalcitonin, TNF-α and IL-6 concentrations, but not the IL-10 concentration. It also reduced serum D-lactic acid and increased sIgA concentrations in intestinal mucosa. Notably, DHFZDG restored gut microbiota diversity and regulated the decrease in Bacteroidetes induced by sepsis, compared with the MCG rats.

Conclusion

DHFZDG may play a protective role in sepsis by alleviating sepsis-induced inflammation and gut barrier damage in rats.

References

【1】
【1】
 
 
Journal of Traditional Chinese Medical Sciences
Pages 37-44

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu F, Yu C, Liu J, et al. Dahuang Fuzi decoction reduces inflammation levels and alleviates intestinal mucosal barrier damage in septic rats. Journal of Traditional Chinese Medical Sciences, 2020, 7(1): 37-44. https://doi.org/10.1016/j.jtcms.2019.12.002

995

Views

14

Downloads

3

Crossref

5

Scopus

Received: 31 March 2019
Revised: 23 December 2019
Accepted: 24 December 2019
Published: 17 January 2020
© 2020 Beijing University of Chinese Medicine.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).